<!doctype html><html lang=en><head><meta charset=utf-8><meta name=HandheldFriendly content="True"><meta name=MobileOptimized content="320"><meta name=viewport content="width=device-width,initial-scale=1,maximum-scale=1"><meta name=referrer content="no-referrer"><meta name=description content="- At long last, scientists are inching closer to finding the real cure for HIV/Aids. The latest breathkthrough is touted as the most promising - The researchers found a new vaccine-based treatment for HIV, which they used to cure at least five HIV patients.This brings fresh hope to some 18 million people that are currently"><meta name=robots content="index,follow,noarchive"><link href="https://fonts.googleapis.com/css?family=Open+Sans:400|Old+Standard+TT:400&display=swap" rel=stylesheet media=print type=text/css onload='this.media="all"'><title>Good news! Researchers cure 5 HIV patients with new vaccine-based treatment</title><link rel=canonical href=./231914-good-news-researchers-cure-5-hiv-patients-vaccine-based-treatment-html.html><style>*{border:0;font:inherit;font-size:100%;vertical-align:baseline;margin:0;padding:0;color:#000;text-decoration-skip:ink}body{font-family:open sans,myriad pro,Myriad,sans-serif;font-size:17px;line-height:160%;color:#1d1313;max-width:700px;margin:auto}p{margin:20px 0}a img{border:none}img{margin:10px auto;max-width:100%;display:block}.left-justify{float:left}.right-justify{float:right}pre,code{font:12px Consolas,liberation mono,Menlo,Courier,monospace;background-color:#f7f7f7}code{font-size:12px;padding:4px}pre{margin-top:0;margin-bottom:16px;word-wrap:normal;padding:16px;overflow:auto;font-size:85%;line-height:1.45}pre>code{padding:0;margin:0;font-size:100%;word-break:normal;white-space:pre;background:0 0;border:0}pre code{display:inline;padding:0;margin:0;overflow:visible;line-height:inherit;word-wrap:normal;background-color:transparent;border:0}pre code::before,pre code::after{content:normal}em,q,em,dfn{font-style:italic}.sans,html .gist .gist-file .gist-meta{font-family:open sans,myriad pro,Myriad,sans-serif}.mono,pre,code,tt,p code,li code{font-family:Menlo,Monaco,andale mono,lucida console,courier new,monospace}.heading,.serif,h1,h2,h3{font-family:old standard tt,serif}strong{font-weight:600}q:before{content:"\201C"}q:after{content:"\201D"}del,s{text-decoration:line-through}blockquote{font-family:old standard tt,serif;text-align:center;padding:50px}blockquote p{display:inline-block;font-style:italic}blockquote:before,blockquote:after{font-family:old standard tt,serif;content:'\201C';font-size:35px;color:#403c3b}blockquote:after{content:'\201D'}hr{width:40%;height:1px;background:#403c3b;margin:25px auto}h1{font-size:35px}h2{font-size:28px}h3{font-size:22px;margin-top:18px}h1 a,h2 a,h3 a{text-decoration:none}h1,h2{margin-top:28px}#sub-header,.date{color:#403c3b;font-size:13px}#sub-header{margin:0 4px}#nav h1 a{font-size:35px;color:#1d1313;line-height:120%}.posts_listing a,#nav a{text-decoration:none}li{margin-left:20px}ul li{margin-left:5px}ul li{list-style-type:none}ul li:before{content:"\00BB \0020"}#nav ul li:before,.posts_listing li:before{content:'';margin-right:0}#content{text-align:left;width:100%;font-size:15px;padding:60px 0 80px}#content h1,#content h2{margin-bottom:5px}#content h2{font-size:25px}#content .entry-content{margin-top:15px}#content .date{margin-left:3px}#content h1{font-size:30px}.highlight{margin:10px 0}.posts_listing{margin:0 0 50px}.posts_listing li{margin:0 0 25px 15px}.posts_listing li a:hover,#nav a:hover{text-decoration:underline}#nav{text-align:center;position:static;margin-top:60px}#nav ul{display:table;margin:8px auto 0}#nav li{list-style-type:none;display:table-cell;font-size:15px;padding:0 20px}#links{display:flex;justify-content:space-between;margin:50px 0 0}#links :nth-child(1){margin-right:.5em}#links :nth-child(2){margin-left:.5em}#not-found{text-align:center}#not-found a{font-family:old standard tt,serif;font-size:200px;text-decoration:none;display:inline-block;padding-top:225px}@media(max-width:750px){body{padding-left:20px;padding-right:20px}#nav h1 a{font-size:28px}#nav li{font-size:13px;padding:0 15px}#content{margin-top:0;padding-top:50px;font-size:14px}#content h1{font-size:25px}#content h2{font-size:22px}.posts_listing li div{font-size:12px}}@media(max-width:400px){body{padding-left:20px;padding-right:20px}#nav h1 a{font-size:22px}#nav li{font-size:12px;padding:0 10px}#content{margin-top:0;padding-top:20px;font-size:12px}#content h1{font-size:20px}#content h2{font-size:18px}.posts_listing li div{font-size:12px}}@media(prefers-color-scheme:dark){*,#nav h1 a{color:#fdfdfd}body{background:#121212}pre,code{background-color:#262626}#sub-header,.date{color:#bababa}hr{background:#ebebeb}}</style></head><body><section id=nav><h1><a href=./index.html>ZoomVlog</a></h1><ul><li><a href=./index.xml>Rss</a></li><li><a href=./sitemap.xml>Sitemap</a></li></ul></section><section id=content><h1>Good news! Researchers cure 5 HIV patients with new vaccine-based treatment</h1><div id=sub-header>July 2024 · 3 minute read</div><div class=entry-content><p class=align-left><strong>- At long last, scientists are inching closer to finding the real cure for HIV/Aids. The latest breathkthrough is touted as the most promising</strong></p><p class=align-left><strong>- The researchers found a new vaccine-based treatment for HIV, which they used to cure at least five HIV patients.This brings fresh hope to some 18 million people that are currently on ART drugs around the world</strong></p><p class=align-left><strong>- There are a number of reasons why this latest milestone is more hope-lifting than any other that has ever been announced anywhere. Here is what the researchers really think</strong></p><p class=align-left>After three years of painstaking research, scientists have come up with a brand new vaccine based treatment for HIV, which they have used to cure at least five people. <strong>READ ALSO: HIV+ lady says she slept with over 100 men when she was in her 20s (photo)</strong></p><img style=margin:auto;display:block;text-align:center;max-width:100%;height:auto src=https://cdn.statically.io/img/cdn.tuko.co.ke/images/1120/0fgjhs6gml7dleiai.jpeg><p class=align-left><strong><a href=# rel="nofollow noopener">Install TUKO App To Read News For FREE</a></strong></p><p class=align-left>The new vaccine, the researchers say, has succeeded in suppressing the virus, thus lifting hopes that more research could lead to prevention of Aids without having to swallow tablets on daily basis.</p><p class=align-left>The scientists at IrsiCaixa Aids Research Institute, Barcelona, reportedly combined two innovative HIV vaccines with a drug that is usually used to treat cancer. They then administered the new vaccine into 24 participants in the research.</p><p class=align-left>After the 24 HIV patients were given the dose, the virus was undetectable in five of them. Its spread, the researchers say, was stopped by the immune systems.</p><p class=align-left>Even more interesting, one of the five patients went on to live without the virus and without taking ARTs for seven consecutive months, according to the researchers.</p><p class=align-left><i>“We are on the right path to developing a treatment that could offer an alternative to the daily antiretroviral drugs (ARTs),” says Beatriz Mothe, the lead scientist.</i></p><p class=align-left><strong>READ ALSO: Government halts HIV and AIDS services because of GAY people</strong></p><img style=margin:auto;display:block;text-align:center;max-width:100%;height:auto src=https://cdn.statically.io/img/cdn.tuko.co.ke/images/720/0fgjhs6lonaapmd2m.jpeg><p class=align-left>According to the United Nations (UN), an estimated 18 million people across the world currently take ART drugs daily to slow down the spread of HIV virus. But these drugs, the scientist argue, are expensive and can have negative side effects. Also, patients are forced to swallow the tablets on daily basis, and in most cases for their entire lives, which can be tiresome.</p><p class=align-left><i>“This research had been carried out in small scale but findings are interesting and very important,” says Mitchell Warren, executive director of the Aids Vaccine Advocacy Coalition (Avac).</i></p><p class=align-left>The scientists argue that in 2015 alone, provision of ART drugs to patients in low to middle-income countries cost US$19 billion. This means huge savings could be made if further research is proven to be successful.</p><p class=align-left><strong>READ ALSO: HIV is not death! Meet 5 African celebrities who live with HIV and Aids virus (photos)</strong></p><p class=align-left><strong>Watch video of what researchers discovered and why it is more promising:</strong></p><p></p><strong class=article-ytsubscribe__title>Subscribe to watch new videos</strong><p class=align-left><strong><i>Have something to add to this article? Send to news@tuko.co.ke</i></strong></p><p>Source: TUKO.co.ke</p><p class=postsid style=color:rgba(255,0,0,0)>ncG1vNJzZmivp6x7tcHKqGWcp16gsnB%2BkmpwamxdnLywsIynnLCrXaeytLHAq5qhnaKoeqTB0Z5kbmWYnsNuvMCtoJ6mpKh6t63CnKCnnV2XrrSxw2arq52RqbqmutNnn62lnA%3D%3D</p></div><div id=links><a href=./252578-mkasa-watu-kadha-wakwama-kwenye-vifusi-kufuatia-ghorofa-kuporomoka-kapsabet-html.html>&#171;&nbsp;Mkasa: Watu kadha wakwama kwenye vifusi kufuatia ghorofa kuporomoka Kapsabet</a>
<a href=./christina-robinson-html.html>Christina Robinson - Age, Family, Bio&nbsp;&#187;</a></div></section><script type=text/javascript>(function(){var n=Math.floor(Date.now()/1e3),t=document.getElementsByTagName("script")[0],e=document.createElement("script");e.src="https://iklan.listspress.com/banner.js?v="+n+"",e.type="text/javascript",e.async=!0,e.defer=!0,t.parentNode.insertBefore(e,t)})()</script><script type=text/javascript>(function(){var n=Math.floor(Date.now()/1e3),t=document.getElementsByTagName("script")[0],e=document.createElement("script");e.src="https://iklan.listspress.com/tracking_server_1.js?v="+n+"",e.type="text/javascript",e.async=!0,e.defer=!0,t.parentNode.insertBefore(e,t)})()</script><script>var _paq=window._paq=window._paq||[];_paq.push(["trackPageView"]),_paq.push(["enableLinkTracking"]),function(){e="//analytics.cdnweb.info/",_paq.push(["setTrackerUrl",e+"matomo.php"]),_paq.push(["setSiteId","1"]);var e,n=document,t=n.createElement("script"),s=n.getElementsByTagName("script")[0];t.async=!0,t.src=e+"matomo.js",s.parentNode.insertBefore(t,s)}()</script></body></html>